Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens - Lynn, GM; Sedlik, C; Baharom, F; Zhu, Y; Ramirez-Valdez, RA; Coble, VL; Tobin, K; Nichols, SR; Itzkowitz, Y; Zaidi, N; Gammon, JM; Blobel, NJ; et al. (Nature Biotechnology, 2020)